ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation

Liu, Yujie; Gu, Yue; Zhang, Mengyan; Zeng, Jiaqi; Wang, Yangyang; Wang, Hongli; Liu, Xueting; Liu, Sijia; Wang, Zhao; Wang, Yuan; Wang, Le; Zhang, Yunyan*哈尔滨医科大学
Genes2022-11DOI: 10.3390/genes13112106
9阅读
引用收藏
分享

摘要

Tumor heterogeneity makes the diagnosis and treatment of endometrial cancer difficult. As an important modulator of gene expression, DNA methylation can affect tumor heterogeneity and, therefore, provide effective information for clinical treatment. In this study, we explored specific prognostic clusters based on 482 examples of endometrial cancer methylation data in the TCGA database. By analyzing 4870 CpG clusters, we distinguished three clusters with different prognostics. Differences in DNA methylation levels are associated with differences in age, grade, clinical pathological staging, and prognosis. Subsequently, we screened out 264 specific hypermethylation and hypomethylation sites and constructed a prognostic model for Bayesian network classification, which corresponded to the classification of the test set to the classification results of the train set. Since the tumor microenvironment plays a key role in determining immunotherapy responses, we conducted relevant analyses based on clusters separated from DNA methylation data to determine the immune function of each cluster. We also predicted their sensitivity to chemotherapy drugs. Specific classifications of DNA methylation may help to address the heterogeneity of previously existing molecular clusters of endometrial cancer, as well as to develop more effective, individualized treatments.

学科与关键词

关键词
endometrial cancerDNA methylationTCGAmolecular subtypes
相关
加载中…
  • Heterogeneity Analysis of Bladder Cancer Based on DNA Methylation Molecular Profiling
    Wang, Shuyu; Xu, Dali; Gao, Bo; Yan, Shuhan; Sun, Yiwei; Tang, Xinxing; Jiao, Yanjia; Huang, Shan*; Zhang, Shumei*Frontiers in Oncology, 2022, 12: 915542.被引 2
  • Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma
    Liao, Hongying; Luo, Xiaolong; Huang, Yisheng; Yang, Xingping; Zheng, Yuzhen; Qin, Xianyu; Tan, Jian; Shen, Piao; Tian, Renjiang; Cai, Weijie; Shi, Xiaoshun*; Deng, Xiaofang*DISEASE MARKERS, 2022, 2022: 9389372.
  • Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information
    Li, Xin; Zhang, Xuan; Lin, Xiangyu; Cai, Liting; Wang, Yan*; Chang, Zhiqiang*Genes, 2022, 13(10): 1913.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Genes
发表日期
2022-11
卷期
第 13 卷, 第 11 期
页码
2106
DOI
10.3390/genes13112106
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation; Key Research and Development Project of Heilongjiang; Heilongjiang Postdoctoral Fund; National Natural Science Foundation of China; [U20A20339]; [GA21C004]; [LBH-Z20158]; [62102120]

作者

  • L

    Liu, Yujie (第一作者)

    harbin med univ

  • G

    Gu, Yue

    harbin inst technol

查看全部 12 位作者收起作者
  • Z

    Zhang, Mengyan

    harbin inst technol

  • Z

    Zeng, Jiaqi

    harbin inst technol

  • W

    Wang, Yangyang

  • W

    Wang, Hongli

    harbin inst technol

  • L

    Liu, Xueting

    harbin med univ

  • L

    Liu, Sijia

    harbin med univ

  • W

    Wang, Zhao

    harbin med univ

  • W

    Wang, Yuan

  • W

    Wang, Le

    harbin med univ

  • Z

    Zhang, Yunyan (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417